RJ-4287

N/A

Report date: 2025/12/02 20:00:12
NME

Base Information

Drug NameRJ-4287
Drug Alias NameRJ-4287
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesOrimos Therapeutics Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesOrimos Therapeutics Co LtdNanjing Ruijie Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse ReactionsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A